Abel Hall LLC’s GoHealth GOCO Stock Holding History

Abel Hall LLC’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,472	Closed	-$22.5K	–	879
2025 Q4	$22.5K	Buy	+10,472	New	+$35.8K	0.01%	697

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

RCM

Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Abel Hall LLC's GOCO Position: Q1 2026 in Review

Abel Hall LLC sold out of GoHealth (GOCO) in Q1 2026, closing a stake of 10,472 shares — an estimated $22.5K sold.

Abel Hall LLC first reported a position in GOCO in Q4 2025 and held it in 1 quarter. The position peaked at $22.5K in Q4 2025. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

Abel Hall LLC reported no remaining GoHealth position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 10,472 GoHealth shares in Q1 2026, an estimated $22.5K.
Abel Hall LLC first reported a position in GoHealth in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's GoHealth position peaked at $22.5K in Q4 2025.
67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.